fingolimod hydrochloride has been researched along with Viral Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garber, K | 1 |
| Brinkmann, V; Merkler, D; Pinschewer, DD | 1 |
1 review(s) available for fingolimod hydrochloride and Viral Diseases
| Article | Year |
|---|---|
Impact of sphingosine 1-phosphate modulation on immune outcomes.
Topics: Animals; Fingolimod Hydrochloride; Gene Expression Regulation; Humans; Immune System; Immunosuppressive Agents; Lymphocytes; Lysophospholipids; Multiple Sclerosis; Propylene Glycols; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Virus Diseases | 2011 |
1 other study(ies) available for fingolimod hydrochloride and Viral Diseases
| Article | Year |
|---|---|
Infections cast cloud over Novartis' MS therapy.
Topics: Drug Industry; Fingolimod Hydrochloride; Humans; Multiple Sclerosis; Propylene Glycols; Sphingosine; Virus Diseases | 2008 |